Published September 30, 2011 | Version v1
Journal article

Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: a review of new avenues in its management

  • 1. Cancer Centre, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022 (China)
  • 2. Department of Oncology, Queen Victoria Hospital, Candos, Quatre-Bornes (Mauritius)

Description

Temporal lobe necrosis (TLN) is the most debilitating late-stage complication after radiation therapy in patients with nasopharyngeal cancer (NPC). The bilateral temporal lobes are inevitably encompassed in the radiation field and are thus prone to radiation induced necrosis. The wide use of 3D conformal and intensity-modulated radiation therapy (IMRT) in the treatment of NPC has led to a dwindling incidence of TLN. Yet, it still holds great significance due to its incapacitating feature and the difficulties faced clinically and radiologically in distinguishing it from a malignancy. In this review, we highlight the evolution of different imaging modalities and therapeutic options. FDG PET, SPECT and Magnetic Spectroscopy are among the latest imaging tools that have been considered. In terms of treatment, Bevacizumab remains the latest promising breakthrough due to its ability to reverse the pathogenesis unlike conventional treatment options including large doses of steroids, anticoagulants, vitamins, hyperbaric oxygen and surgery

Availability note (English)

Available from http://dx.doi.org/10.1186/1748-717X-6-128; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195720

Additional details

Publishing Information

Journal Title
Radiation Oncology (Online)
Journal Volume
6
Journal Page Range
p. 128
ISSN
1748-717X

Optional Information

Copyright
Copyright (c)2011 Chen et al
Notes
PMCID: PMC3195720; PUBLISHER-ID: 1748-717X-6-128; PMID: 21961805; OAI: oai:pubmedcentral.nih.gov:3195720; licensee BioMed Central Ltd.